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INTRODUCTION
The diagnosis of neuro-Beh et’s disease (NBD) can be dif-
ficult when the central nervous system (CNS) involvement
precedes the mucocutaneous involvement or when the his-
tory of mucocutaneous lesion is incomplete or absent (1, 2).
In these cases, magnetic resonance (MR) imaging study and
cerebrospinal fluid examinations may be helpful in differen-
tiating NBD from other neurologic diseases with similar
clinical presentations (3-5). However, a brain tumor can not
be ruled out if the radiologic findings of NBD show a mass
(6-10).
The pseudotumoral form of NBD has rarely been reported.
In such cases, NBD was diagnosed by stereotactic biopsy or
dependent on the clinical diagnostic criteria of International
Study Group for Beh et’s disease (6-10). As far as we know,
the temporal lobectomy has not been previously reported in
pseudotumoral form of NBD. Moreover, all the documented
cases had relatively good prognosis showing steroid respon-
siveness. We experienced a case of NBD presenting as recur-
rences and disappearances of mass lesions in the brain and
finally as an impending cerebral hernia requiring decompres-
sive surgery.
CASE REPORT
A 52-yr-old woman was admitted to the neurology depart-
ment of our hospital with dizziness, nausea, and vomiting in
April 1996. Her past medical and family history was non-
specific. Neurologic examinations revealed Brun’s nystagmus,
suggesting a right cerebello-pontine angle lesion. Routine
laboratory parameters were not remarkable. T2-weighted
MR image (T2WI) showed an extensive high signal intensity
in the right cerebellar hemisphere, posterior medulla, and
pons with an isosignal central mass. Gadolinium-enhanced
T1-weighted MR image (Gd-T1WI) showed a homogenous-
ly enhancing mass-like lesion inside the T2 high signal inten-
sity (Fig. 1A). We suspected a cerebellar tumor from the clini-
cal and imaging features but steroid treatment was started
initially. Two weeks later, the mass nearly disappeared on
follow-up MR image (Fig. 1B). Biopsy was not performed
because of its location and clinical and radiological improve-
ment.
One year later, she visited the rheumatology department
of our hospital because of recurrent headaches, visual distur-
bance, oral ulcerations, erythema nodosum-like skin lesions,
and arthritis. The skin biopsy revealed nonspecific vasculi-
tis. She had no genital ulcer. She was diagnosed as Beh et’s
disease. And immunosuppressant and steroid maintenance
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Neuro-Behcet's Disease Mimicking a Cerebral Tumor
: A Case Report
We report a rare case of neuro-Beh et's disease (NBD) presenting as an inflam-
matory pseudotumor in the brain. A 52-yr-old woman was evaluated for subacute
dizziness and headache. Brain magnetic resonance (MR) imaging showed a right
cerebellar mass, which disappeared 2 weeks later. After a year, recurrent muco-
cutaneous manifestations of Beh et's disease were observed. Immunosuppres-
sant and steroid maintenance treatment were started. She experienced two more
neurologic attacks and brain MR imaging revealed an enhancing mass in the right
temporal lobe. The second attack showed a good response to steroid pulse ther-
apy, but the third attack did not respond to steroid and her neurologic signs sug-
gested an impending transtentorial hernia. The right temporal lobectomy was per-
formed for the purpose of life-saving. The pathologic finding of the mass was a
chronic inflammatory vasculitis, compatible with NBD.
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therapy were started.
In January 1999, she had the second neurologic attack man-
ifested by subacute headache, confusion, poor feeding, and
vomiting. On neurologic examinations, a mild attention de-
ficit, immediate memory impairment, visuo-spatial disori-
entation, and wide-based unsteady gait were noted. Labora-
tory studies including CSF study were normal. Brain MR
imaging demonstrated a homogenously enhancing solid mass-
like lesion in the right temporal white matter with surround-
ing edema (Fig. 2A). She was treated with high-dose steroid
(methylprednisolone 1,000 mg/day) for a week and became
fully recovered. CSF study revealed pressure of 180 mm H2O,
lymphocytes 25 per  L, protein 300 mg/dL, and normal glu-
cose concentration. No malignant cells were seen. Other CSF
studies including IgG index, oligoclonal band, myelin basic
protein, anti-cytomegalovirus antibody, and anti-herpes sim-
plex virus antibody were either normal or negative. Follow-
up MRI after 2 months showed little evidence of the previous
lesion (Fig. 2B). Maintenance doses of prednisolone and aza-
thioprin (300 mg/day) were continued.
Her third attack was in July 1999. On neurologic exami-
nations, left homonymous hemianopsia, left hemiparesis,
and left extensor plantar reflex were represented. MR imag-
ing revealed nearly same findings as previous ones except
slightly changed shape and location in the right temporal
area (Fig. 3A). In spite of high-dose steroid and hypertonic
solution (25% mannitol 1.0 g/kg body weight), her neuro-
logic symptoms and signs got more and more worsened. She
fell into stuporous consciousness with bilateral long tract
signs. Right temporal lobectomy was done for decompression
of impending herniation. After the temporal lobectomy (Fig.
3B), she regained alert mental state without physical impair-
ments, but her condition was slowly deteriorated to almost
a bed-ridden state with cognitive impairment over the next 5
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Fig. 1. MRI at the first neurologic attack
shows a homogenously enhancing lobu-
lated mass extending to the fourth ventri-
cle on gadolinium-enhanced T1-weighted
axial image (A). The mass lesion almost
disappeared after steroid treatment for 2
weeks (B).
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Fig. 2. Gd-enhanced T1-weighted MRI at
the second neurologic attack shows a lob-
ulated mass in the right temporal area (A),
which also almost disappeared, after steroid
treatment (B).720 J.-H. Park, M.-K. Jung, C.-O. Bang, et al.
months. She died of respiratory complication after 46 months
from the first neurologic attack.
Pathology
No malignant cells were seen on frozen sections. Patholog-
ic characteristics of the specimen were multifocal ill-defined
old ischemic lesions and lymphocytic vasculitis involving
small and medium-sized vessels (mainly veins) of white mat-
ter accompanied by focal cortical dysplasia. Old ischemic
lesions were composed of a proliferation of small and capil-
lary vessels with congestion, perivascular infiltration of small
mature lymphocytes, histiocytes, and a few plasma cells, hya-
line thickening of small vessel walls, and reactive astrocytosis.
Multi-layered perivascular lymphocytic infiltration showed
the characteristic vascular cuffings (Fig. 4A). In the Luxol-
Fast-Blue stain, the myelin fibers were relatively well pre-
served in the old ischemic lesions (Fig. 4B). Some lympho-
cytes were spread into the brain parenchyma, which showed
liquefaction (softening). The cortex was mostly well preserved,
however, focal areas of the cortex, adjacent to the old ischemic
lesion, showed histologic features of focal cortical dysplasia,
such as disorganized neuronal cells, subpial gliosis, scattered
heterotopic neuronal cells in the white matter, and a few bal-
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Fig. 3. MRI at the third neurologic attack (A)
shows a densely enhancing mass with mid-
line shifting in the right temporal deep white
matter on gadolinium-enhanced T1-weight-
ed axial image. Prominent edema around
the mass is shown (arrow). MRI after resec-
tion of the temporal mass (B) shows neither
a mass lesion nor midline shifting.
Fig. 4. (A) Histologic specimen discloses lymphocytic vasculitis with the typical vascular cuffing (H&E,×100). (B) Myelin fibers are rela-
tively well preserved (Luxol-Fast-Blue,×100).
A BBeh et's Disease Mimicking a Cerebral Tumor 721
loon cells in the white matter. Ill-defined reactive ischemic
lesions and focal cortical dysplastic changes might be related
to the chronic ischemia due to multifocal brain parenchymal
lymphocytic vasculitis. These findings suggested nonspecific
inflammatory vasculitic process of the disease, which appears
to play a central role in the pathogenesis of NBD.
DISCUSSION
The NBD was introduced by Cavara and d’Ermo in 1954
(1). The rate of CNS involvement in Beh et’s disease is vari-
able from 4% to 49% (1-3). Usually, most of CNS involve-
ments occur several months or years after mucocutaneous or
ocular symptoms. However about 5% of patients may not
develop the mucocutaneous manifestations until the neuro-
logic manifestaitions occur (3, 11).
In most reports, the patients with pseudotumoral NBD on
imaging studies had preceding neurologic manifestations or
had vague mucocutaneous manifestations (6-10). Brain MR
imaging or computed tomography (CT) were not helpful for
the differential diagnosis because the findings of NBD could
be the same as those of multiple sclerosis and cerebral tumor,
especially cerebral lymphoma. Thus, they reached the final
diagnosis by biopsy to exclude cerebral tumor or by clinical
observation until mucocutaneous symptoms met the criteria
of Beh et’s disease recommended by the international study
group.
At the onset of the disease, our patient did not meet the
criteria for the diagnosis of Beh et’s disease. So, we diagnosed
the patient as having a tumor. After one year, she showed
typical recurrent oral ulceration, biopsy proven skin lesion,
and uveitis. This time, we diagnosed her as NBD, based on
clinical criteria of Beh et’s disease, but could not exclude the
possibility of other similar diseases including multiple scle-
rosis, neurosarcoidosis, and brain tumor. Relapsing mass-like
lesion is very unusual in NBD and favors to CNS lymphoma.
This made the diagnosis suspicious until the biopsy. We could
not find any neoplastic lymphoid cells throughout the biop-
sy specimens. Moreover, vasculitis of small vessels, mainly of
venules, is a characteristic feature of Beh et’s syndrome (12).
There is some consensus about MR imaging findings of
NBD. The common distribution of the lesion is mesencepha-
lo-diencephalic junction (1-5, 13). Although still on debate,
a confluent lesion extending from the brain stem to dience-
phalic structures and basal ganglia in T2WI is a characteris-
tic feature in acute stage of NBD. Brain stem atrophy with-
out cortical atrophy can be observed in chronic stage of NBD
(3, 5, 13). The NBD presenting as a mass-like lesion on CT
or MRI is rare, but already described previously (6-10). The
location of the mass seems to have no predilection in the brain.
Interestingly, all cases were favorable to steroid treatment at
least in short-term follow-up. The long-term follow-up results
were not well documented. Thus, it is uncertain whether
the long-term prognosis of pseudotumoral form of NBD is
favorable or not. In our case, the mass responded to steroid
treatment at the first and second occasions, but the last one
did not.
Histological findings of NBD may be variable according
to the treatment and stage of the disease, but usually reveal
following features: perivascular cuffing of small lymphocytes,
microcystic softening, demyelination, and gliosis (14-16).
Some authors reported acute neutrophilic inflammation with-
out vasculitis in a fulminant form of NBD (16). In pseudo-
tumoral form of NBD, a few examples of biopsy have been
reported. Geni et al. reported mild perivascular inflammation
without necrosis and Park et al. reported perivascular lym-
phocytic infiltration, secondary gliosis, petechial hemorrhage,
and hemosiderin with or without demyelination (6, 10). In
addition to these findings, plasma cell infiltration, hyaline
thickening of the vascular wall, and ischemic necrotic foci as
shown in our case may reflect the long duration of inflamma-
tory process. NBD shows variable response to steroid treat-
ment (10, 16, 17). However, it is accepted that acute inflam-
mation is more favorable to steroid treatment and has better
prognosis than chronic inflammation (4, 10, 17). Histologic
evidence of chronic inflammation in our case could explain
the unresponsiveness to steroid therapy and poor prognosis.
In summary, we report a case of pseudotumoral form of
NBD, of which the diagnosis was greatly hampered by atypi-
cal imaging features with recurrent mass-like lesions. We
emphasize that if pseudotumoral NBD is suspected, more
meticulous and aggressive approach including stereotactic
biopsy as well as, if needed, resection should be done for more
precise diagnosis and prognostic information. To elucidate
the prognostic implications of the pseudotumoral form of
NBD, more case reports or studies are needed.
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